Nevro
NVRO
$11.32
Share price
-2.58%
Change (1 day)
-62.66%
Change (1 year)
Categories
Nevro (NVRO) - Cash on Hand
Cash on Hand as of December 2023 : $0.32 B
According to Nevro
's latest financial reports the company has $0.32 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nevro - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.32 B | -13.8% |
| 2022-12-31 | $0.37 B | 3.41% |
| 2021-12-31 | $0.36 B | -38.43% |
| 2020-12-31 | $0.58 B | 147.25% |
| 2019-12-31 | $0.23 B | -10.11% |
| 2018-12-31 | $0.26 B | -1.77% |
| 2017-12-31 | $0.26 B | -2.55% |
| 2016-12-31 | $0.27 B | 42.69% |
| 2015-12-31 | $0.19 B | 9.54% |
| 2014-12-31 | $0.17 B | 212.76% |
| 2013-12-31 | $56.53 M | 84.65% |
| 2012-12-31 | $30.61 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $8.07 B | 2,402.77% | 🇺🇸 USA |
 Abiomed ABMD | $0.82 B | 154.20% | 🇺🇸 USA |
 Intuitive Surgical ISRG | $5.22 B | 1,518.48% | 🇺🇸 USA |
 Orthofix Medical
OFIX | $33.1 M | -89.74% | 🇺🇸 USA |